| Literature DB >> 17499121 |
Adriana Galvan1, Thomas Wichmann.
Abstract
GABA is the major inhibitory neurotransmitter in the basal ganglia, and GABAergic pathways dominate information processing in most areas of these structures. It is therefore not surprising that abnormalities of GABAergic transmission are key elements in pathophysiologic models of movement disorders involving the basal ganglia. These include hypokinetic diseases such as Parkinson's disease, and hyperkinetic diseases, such as Huntington's disease or hemiballism. In this chapter, we will briefly review the major anatomic features of the GABAergic pathways in the basal ganglia, and then describe in greater detail the changes of GABAergic transmission, which are known to occur in movement disorders.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17499121 DOI: 10.1016/S0079-6123(06)60017-4
Source DB: PubMed Journal: Prog Brain Res ISSN: 0079-6123 Impact factor: 2.453